GE Healthcare Takes Additional Actions to Help Clinicians Combat Coronavirus
March 24 2020 - 7:30AM
Business Wire
GE Healthcare and Ford collaborate to
accelerate and scale ventilator production, supporting clinicians
in the treatment of COVID-19 patients
GE Healthcare provides information to
clinicians who are considering the use of anesthesia systems to
ventilate COVID-19 patients, following FDA guidance
GE Healthcare today provided two updates on its continued
efforts to support clinicians, governments and the broader
healthcare community in the fight against the coronavirus
(COVID-19).
GE Healthcare and Ford Motor Company will work together to scale
the production of ventilators, arming clinicians with medical
equipment important in the treatment of COVID-19 patients. Through
this collaboration, Ford will provide its technical and production
expertise with the goal of manufacturing a simplified design of GE
Healthcare’s existing ventilator. This new system would be built
specifically to address urgent needs during the pandemic, equipped
with the essential functions required to safely treat COVID-19
patients.
“We are encouraged by how quickly companies from across
industries have mobilized to help address the growing challenge we
collectively face from COVID-19,” said GE Healthcare president and
CEO Kieran Murphy. “We are proud to bring our clinical and
technical expertise to this collaboration with Ford, working
together to serve unprecedented demand for this life-saving
technology and support clinicians as they meet patient needs.”
“We’re so proud to be working closely with GE Healthcare on this
important effort, and we have empowered our teams of engineers and
designers to be scrappy and creative to quickly help scale up their
production of this vital equipment,” said Jim Hackett, Ford’s
president and CEO.
Additionally, in alignment with the U.S. Food and Drug
Administration’s (FDA) guidance, GE Healthcare has provided
information on its website on the use of its anesthesia devices for
patients requiring mechanical ventilation. This information helps
make ventilation capabilities more widely available to support
patients with respiratory failure or difficulty breathing caused by
COVID-19. Clinicians can use these details in the treatment of
patients at their discretion. As a leading global provider of
anesthesia devices with a global installed base of over 100,000
devices, this update provides immediate assistance in the global
demand of ventilators.
This update follows an earlier statement from Murphy around the
company’s efforts to increase its manufacturing capacity for
medical equipment, including ventilators. Since the COVID-19
outbreak began, GE Healthcare has doubled its capacity of
ventilator production and has plans to double it again by end of Q2
2020 to address unprecedented demand – independent of the
collaboration with Ford.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200324005349/en/
Media contact: Amy Sarosiek Executive Director, External
Communications GE Healthcare +1 224 239 6028
amy.sarosiek@ge.com
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Aug 2024 to Sep 2024
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Sep 2023 to Sep 2024